SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10KSB - Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405]:
SEC Accession No. 0000950120-07-000525
Filing Date
2007-09-26
Accepted
2007-09-26 13:11:40
Documents
8
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT FOR F/Y/E DECEMBER 31, 2006 form10-ksb.htm 10KSB 1086189
2 HENRY MORGAN CHANGE OF CONTROL AGREEMENT exh10_21.htm EX-10.21 26727
3 MICHAEL SCHAMROTH CHANGE OF CONTROL AGREEMENT exh10_22.htm EX-10.22 26874
4 PAUL GITMAN CHANGE OF CONTROL AGREEMENT exh10_23.htm EX-10.23 27002
5 CONSENT OF INDEPENDENT ACCOUNTING FIRM exh23_1.htm EX-23.1 5094
6 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER PUR exh31_1.htm EX-31.1 16512
7 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER PUR exh32_1.htm EX-32.1 7546
8 CPA LOGO cpalogo.jpg GRAPHIC 18389
  Complete submission text file 0000950120-07-000525.txt   1222800
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10KSB | Act: 34 | File No.: 000-19879 | Film No.: 071136081
SIC: 2834 Pharmaceutical Preparations